Insider trade

Immunocore Holdings (IMCR): HEAD OF R&D sold ~$44K

David M Berman, HEAD OF R&D at Immunocore Holdings, sold ~$44K of Immunocore Holdings shares.

~$44K
Approx. value · 1,200 sh @ $36.77
Traded
Sep 10, 2025
Filed
Sep 12, 2025

What stands out in this filing

  • The sale emptied this holding: the filing reports no shares left in it afterwards.
  • 1,200 shares at an average of $36.77 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 10, 2025 · this disclosureInsiderOfficer sold ~$44K of IMCR shares in the open market

What came next

  1. Sep 10, 2025InsiderOfficer sold ~$1.09M of IMCR shares in the open market
  2. Sep 11, 2025InsiderOfficer sold ~$692K of IMCR shares in the open market
  3. Sep 12, 2025Insider · 1 personInsiders: 2 sales (~$804K)
  4. Sep 15, 2025InsiderOfficer sold ~$7K of IMCR shares in the open market
  5. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  6. Nov 26, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 26, 2025, Ranjeev Krishana notified the board of directors (the “Board”) of Immunocore Holdings plc (the “Company”) of his decision to resign as a member of the Board and a member of the Remuneration Committee of the Board, effective immediately.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Immunocore Holdings

For Immunocore Holdings, OQRO holds 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMCR page.

Other recent filings by David M Berman, HEAD OF R&D

The full history of David M Berman, HEAD OF R&D is on the profile page.

How this filing works

Explore the data

Common questions

Which Immunocore Holdings (IMCR) insider traded, and how much?

David M Berman, HEAD OF R&D at Immunocore Holdings, sold ~$44K of Immunocore Holdings shares. 1,200 shares at $36.77.

When did it happen, and when was it made public?

Traded: Sep 10, 2025. Filed: Sep 12, 2025. That is 2 days between the two dates.

What stands out in this filing?

The sale emptied this holding: the filing reports no shares left in it afterwards. 1,200 shares at an average of $36.77 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Immunocore Holdings recently?

For Immunocore Holdings, OQRO holds 4 fund holdings reports (13F) dated in the last 90 days. They are listed on the IMCR page.

Does this mean IMCR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Immunocore Holdings

Everything OQRO holds on this company is on its IMCR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data